These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22811421)

  • 21. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 22. CMR-determined scar volume: predictive for ventricular tachycardias?
    van der Wall EE; Zeppenfeld K; Bax JJ; Siebelink HM; Schalij MJ
    Int J Cardiovasc Imaging; 2011 Oct; 27(7):989-93. PubMed ID: 21061171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive imaging markers associated with sudden cardiac death.
    van der Bijl P; Delgado V; Bax JJ
    Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
    Zeidan-Shwiri T; Yang Y; Lashevsky I; Kadmon E; Kagal D; Dick A; Laish Farkash A; Paul G; Gao D; Shurrab M; Newman D; Wright G; Crystal E
    Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 31. Aborted sudden cardiac death: ICD or no ICD.
    Lachmann V; Makimoto H; Kelm M; Bönner F
    Clin Res Cardiol; 2017 Sep; 106(9):760-763. PubMed ID: 28396986
    [No Abstract]   [Full Text] [Related]  

  • 32. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 33. Interference of subcutaneous implantable cardioverter defibrillator by deep brain stimulation.
    Nayak HM; Sauser E; Xie T
    Parkinsonism Relat Disord; 2020 Dec; 81():75-77. PubMed ID: 33075699
    [No Abstract]   [Full Text] [Related]  

  • 34. Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD.
    Khattak A; Charytan DM
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1107-9. PubMed ID: 26111858
    [No Abstract]   [Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillator therapy in the elderly: the continuing quest for data.
    Barsheshet A; Huang DT
    Cardiol J; 2011; 18(5):473-5. PubMed ID: 21947981
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of implantable cardioverter defibrillator in nonischaemic cardiomyopathy: a U-turn?
    Gaita F; Castagno D; Anselmino M
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e63-e67. PubMed ID: 29084020
    [No Abstract]   [Full Text] [Related]  

  • 37. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ; Exner DV; Wathen MS; Sherfesee L; Scinicariello AP; Gillberg JM
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):280-9. PubMed ID: 20958831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond the implantable cardioverter-defibrillator: are we making progress?
    Weiss JN
    Heart Rhythm; 2008 Jun; 5(6 Suppl):S45-7. PubMed ID: 18456201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inappropriately Appropriate.
    Asirvatham SJ; Stevenson WG
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003608. PubMed ID: 26902147
    [No Abstract]   [Full Text] [Related]  

  • 40. An adolescent with laminopathy presenting as ventricular tachycardia and left ventricular apical aneurysm.
    Kwon HW; Kwon BS; Bae EJ; Chae JH
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1419. PubMed ID: 25187606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.